Cardiovascular Diseases

The grounding supports a multifactorial etiology rather than a single cause. It includes modifiable risk factors and exposures such as abnormal lipids, glucose dysregulation, obesity, hypertension, aging, diet, exercise patterns, oxidative stress, gastrointestinal microbiome-related mechanisms, and endocrine-disrupting chemicals.

The literature points to altered metabolic and inflammatory signaling, oxidative stress, and changes in cardiac structure and function as part of disease biology. It also highlights pathways involving lipids, glucose metabolism, cytokines, C-reactive protein, proprotein convertase 9, angiotensin-converting enzyme 2, and gastrointestinal hormone receptors, with broader physiopathology spanning vascular and cardiac injury.

Supported risk factors include obesity, diabetes, hypertension, aging, adverse lipid profiles, and broader lifestyle-related factors such as diet and exercise patterns. The grounding also identifies social relationships as associated with mortality risk and includes endocrine-disrupting chemicals as a public health concern linked to cardiovascular endocrinology.

Management is described at the level of therapeutic lifestyle changes and cholesterol-lowering therapy, especially statin-based treatment for high-risk patients. The grounding also supports broader prevention and control approaches, including lipid management, aspirin, and newer metabolic therapies studied in cardiovascular contexts such as GLP-1 receptor agonist-based agents and related incretin therapies.